RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas. [electronic resource]
Producer: 20130924Description: 444-57 p. digitalISSN:- 2159-8290
- Adenocarcinoma -- drug therapy
- Adenocarcinoma of Lung
- Animals
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Female
- Focal Adhesion Protein-Tyrosine Kinases -- antagonists & inhibitors
- Genes, ras -- genetics
- Humans
- Lung Neoplasms -- drug therapy
- Mice
- Mice, Nude
- Mice, Transgenic
- Protein Kinase Inhibitors -- therapeutic use
- Signal Transduction
- Xenograft Model Antitumor Assays
- rhoA GTP-Binding Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.